ACADIA Pharmaceuticals Inc. (LON:0A4W)
18.62
-0.02 (-0.11%)
At close: Jan 31, 2025
ACADIA Pharmaceuticals Market Cap
ACADIA Pharmaceuticals has a market cap or net worth of 2.96 billion as of September 17, 2025. Its market cap has increased by 44.01% in one year.
Market Cap
2.96B
Enterprise Value
2.44B
Revenue
743.68M
Ranking
n/a
PE Ratio
18.27
Stock Price
18.62
Market Cap Chart
Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from 61.44M to 2.96B, an increase of 4,720.72%. That is a compound annual growth rate of 19.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 16, 2025 | 2.96B | 21.45% |
Dec 31, 2024 | 2.44B | -39.57% |
Dec 29, 2023 | 4.04B | 88.62% |
Dec 30, 2022 | 2.14B | -22.79% |
Dec 31, 2021 | 2.77B | -55.49% |
Dec 31, 2020 | 6.22B | 25.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 182.89B |
HSBC Holdings | 173.69B |
Shell | 153.74B |
Unilever | 115.27B |
Rolls-Royce Holdings | 94.89B |
British American Tobacco p.l.c. | 90.77B |
Rio Tinto Group | 78.69B |
BP p.l.c. | 64.96B |